Qing Ling Yu
Chief Executive Officer at Beijing Advaccine Biotechnology Co., Ltd.
Profile
Qing Ling Yu is currently the President, General Manager & Executive Director at Beijing Advaccine Biotechnology Co., Ltd.
Prior to this, she obtained an undergraduate degree from the University of International Business & Economics in 2001.
Qing Ling Yu active positions
| Companies | Position | Start |
|---|---|---|
Beijing Advaccine Biotechnology Co., Ltd.
 Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | Chief Executive Officer | 2009-04-07 |
Training of Qing Ling Yu
| University of International Business & Economics | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
 | Health Technology |
- Stock Market
- Insiders
- Qing Ling Yu
